Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Want to see HK:2157 full AI Analyst Report?
Comparison Results
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$7.99B
9.33
0.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$18.48
HK$15.76B
-27.65
135.71%
1 Buy
1 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$17.22B
-8.22
46.77%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.20B
-75.25
-15.24%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$20.67B
25.33
299.68%
―
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.00B
-8.57
-52.46%
―
Performance Comparison
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.43
0.13
3.02%
HK:1672
Ascletis Pharma, Inc.
14.85
8.23
124.32%
HK:2162
Keymed Biosciences, Inc.
61.35
20.65
50.74%
HK:2171
CARsgen Therapeutics Holdings Ltd.
17.63
-5.07
-22.33%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
50.60
35.94
245.16%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
3.57
-6.09
-63.04%